Europe Multiplex Assay Market 2021-2028

This report calculated that the European multiplex assay market is predicted to exhibit growth at a compound annual growth rate of 8.30% during 2021-2028. Spain, Russia, the United Kingdom, Italy, France, Germany, and Rest of Europe shape the market in this region.

In France, the market is mainly driven by a program related to the development of clinical trials, genome sector, and multiplex assay technologies. Moreover, several other government programs are promoting industrial and academic collaborations to facilitate the discovery of advanced products and technologies. According to the World Population Ageing 2019 report, the population aged 65 years and above is estimated to increase by 2030. Furthermore, several scientific initiatives have been taken in the country, which is estimated to drive the growth of the multiplex assay market across France.

Similarly, Italy is likely to enhance its research and development expenditure, along with the adoption of various devices, which will enhance the growth of the market. Moreover, the rise in the aging population is likely to increase the prevalence of chronic diseases, influencing the need for advanced healthcare services. In this regard, healthcare expenditure has surged over the past few years, which has encouraged the need for molecular-based PCR tests. Therefore, this rise in healthcare expenditure will propel the multiplex assay market on a growth path within Italy.

COMPETITIVE OUTLOOK

The key companies in the multiplex assay market consist of Becton Dickinson and Company, Randox Laboratories Ltd, Illumina Inc, Abcam, Meso Scale Diagnostics LLC, Seegene Inc, Merck Millipore, and Agilent Technologies Inc.

1. Europe Multiplex Assay Market - Summary

2. Industry Outlook

2.1. Impact of COVID-19 on Multiplex Assay Market
2.2. Key Insights
2.3. Porter's Five Forces Model
2.3.1. Threat of New Entrants
2.3.2. Threat of Substitute Products
2.3.3. Bargaining Power of Buyers
2.3.4. Bargaining Power of Suppliers
2.3.5. Competitive Rivalry
2.4. Key Buying Outlook
2.5. Market Attractiveness Index
2.6. Vendor Scorecard
2.7. Key Market Strategies
2.7.1. Contracts and Partnerships
2.7.2. Business Expansions, Announcements, & Divestitures
2.7.3. Acquisitions & Mergers
2.7.4. New Product Launches & Developments
2.8. Key Drivers
2.8.1. Adoption of Personalized Medicines
2.8.2. High Adoption of Multiplex Assays Over Traditional Methods
2.9. Key Restraints
2.9.1. Dearth of Skilled Professionals
2.9.2. Legal Trends Related to Environmental Safety
2.10. Key Opportunities
2.10.1. Funding for R&D Activities by Various Government Agencies and Companies

3. Europe Multiplex Assay Market - by Product and Service

3.1. Reagents and Consumables
3.2. Instruments and Accessories
3.3. Software and Services

4. Europe Multiplex Assay Market - by Type

4.1. Protein-Based Multiplex Assay
4.2. Nucleic Acid-Based Multiplex Assay
4.3. Other Multiplex Assays

5. Europe Multiplex Assay Market - by Application

5.1. Research and Development
5.2. Clinical Diagnostics
5.3. Companion Diagnostics

6. Europe Multiplex Assay Market - by Technology

6.1. Multiplex Protein Microarray
6.2. Multiplex Pcr
6.3. Other Technologies

7. Europe Multiplex Assay Market - by Industry Verticals

7.1. Pharmaceutical & Biotechnology Companies
7.2. Research Institutes
7.3. Clinical Laboratories
7.4. Hospitals

8. Europe Multiplex Assay Market - Country Outlook

8.1. Country Analysis
8.1.1. Germany
8.1.2. France
8.1.3. United Kingdom
8.1.4. Italy
8.1.5. Russia
8.1.6. Spain
8.1.7. Rest of Europe

9. Competitive Landscape

9.1. Abcam
9.2. Agilent Technologies Inc
9.3. Becton Dickinson and Company
9.4. Bio Rad Laboratories Inc
9.5. Bio Techne Corporation
9.6. F Hoffmann La Roche
9.7. Illumina Inc
9.8. Luminex Corporation
9.9. Merck Millipore
9.10. Meso Scale Diagnostics LLC
9.11. Olink Proteomics Ab
9.12. Qiagen Nv
9.13. Randox Laboratories Ltd
9.14. Seegene Inc
9.15. Siemens Healthineers AG
9.16. Thermo Fisher Scientific Inc

10. Research Methodology & Scope

10.1. Research Scope & Deliverables
10.1.1. Objectives of Study
10.1.2. Scope of Study
10.2. Sources of Data
10.2.1. Primary Data Sources
10.2.2. Secondary Data Sources
10.3. Research Methodology
10.3.1. Evaluation of Proposed Market
10.3.2. Identification of Data Sources
10.3.3. Assessment of Market Determinants
10.3.4. Data Collection
10.3.5. Data Validation & Analysis

List of Tables

Table 1: Europe Multiplex Assay Market, Country Outlook, 2021-2028 (In $ Million)
Table 2: Vendor Scorecard
Table 3: Contracts and Partnerships
Table 4: List of Business Expansions, Announcements, & Divestitures
Table 5: Acquisitions & Mergers
Table 6: List of New Product Launches & Developments
Table 7: Europe Multiplex Assay Market, by Product and Service, 2021-2028 (In $ Million)
Table 8: Europe Multiplex Assay Market, by Type, 2021-2028 (In $ Million)
Table 9: Europe Multiplex Assay Market, by Application, 2021-2028 (In $ Million)
Table 10: Europe Multiplex Assay Market, by Technology, 2021-2028 (In $ Million)
Table 11: Europe Multiplex Assay Market, by Industry Verticals, 2021-2028 (In $ Million)
Table 12: Europe Multiplex Assay Market, Country Outlook, 2021-2028 (In $ Million)

List of Figures

Figure 1: Europe Multiplex Assay Market 2021-2028 (In $ Million)
Figure 2: Europe Multiplex Assay Market, by Product and Service, 2020 & 2028 (In %)
Figure 3: Europe Multiplex Assay Market, by Reagents and Consumables, 2021-2028 (In $ Million)
Figure 4: Europe Multiplex Assay Market, by Instruments and Accessories, 2021-2028 (In $ Million)
Figure 5: Europe Multiplex Assay Market, by Software and Services, 2021-2028 (In $ Million)
Figure 6: Europe Multiplex Assay Market, by Type, 2020 & 2028 (In %)
Figure 7: Europe Multiplex Assay Market, by Protein-Based Multiplex Assay, 2021-2028 (In $ Million)
Figure 8: Europe Multiplex Assay Market, by Nucleic Acid-Based Multiplex Assay, 2021-2028 (In $ Million)
Figure 9: Europe Multiplex Assay Market, by Other Multiplex Assays, 2021-2028 (In $ Million)
Figure 10: Europe Multiplex Assay Market, by Application, 2020 & 2028 (In %)
Figure 11: Europe Multiplex Assay Market, by Research and Development, 2021-2028 (In $ Million)
Figure 12: Europe Multiplex Assay Market, by Clinical Diagnostics, 2021-2028 (In $ Million)
Figure 13: Europe Multiplex Assay Market, by Companion Diagnostics, 2021-2028 (In $ Million)
Figure 14: Europe Multiplex Assay Market, by Technology, 2020 & 2028 (In %)
Figure 15: Europe Multiplex Assay Market, by Multiplex Protein Microarray, 2021-2028 (In $ Million)
Figure 16: Europe Multiplex Assay Market, by Multiplex Pcr, 2021-2028 (In $ Million)
Figure 17: Advantages of Immunohistochemistry (Ihc)
Figure 18: Europe Multiplex Assay Market, by Other Technologies, 2021-2028 (In $ Million)
Figure 19: Europe Multiplex Assay Market, by Industry Verticals, 2020 & 2028 (In %)
Figure 20: Europe Multiplex Assay Market, by Pharmaceutical & Biotechnology Companies, 2021-2028 (In $ Million)
Figure 21: Europe Multiplex Assay Market, by Research Institutes, 2021-2028 (In $ Million)
Figure 22: Europe Multiplex Assay Market, by Clinical Laboratories, 2021-2028 (In $ Million)
Figure 23: Europe Multiplex Assay Market, by Hospitals, 2021-2028 (In $ Million)
Figure 24: Germany Multiplex Assay Market 2021-2028 (In $ Million)
Figure 25: France Multiplex Assay Market 2021-2028 (In $ Million)
Figure 26: United Kingdom Multiplex Assay Market 2021-2028 (In $ Million)
Figure 27: Italy Multiplex Assay Market 2021-2028 (In $ Million)
Figure 28: Russia Multiplex Assay Market 2021-2028 (In $ Million)
Figure 29: Spain Multiplex Assay Market 2021-2028 (In $ Million)
Figure 30: Rest of Europe Multiplex Assay Market 2021-2028 (In $ Million)